Immune to Cancer: The CRI Blog
-
Kidney Cancer and Immunotherapy with Dr. Saby George at the 2020 CRI Virtual Immunotherapy Patient Summit
Dr. Saby George discusses the latest updates in immunotherapy for kidney cancer at the 2020 CRI Virtual…
-
Colorectal Cancer and Immunotherapy with Dr. Scott Kopetz at the 2020 CRI Virtual Immunotherapy Patient Summit
Dr. Scott Kopetz discusses new advances and promising research in immunotherapy for colorectal cancer patients.
-
CRI ImmunoAdvocate Perspective: Lung Cancer Survivor Oswald Shares His Immunotherapy Experience
CRI ImmunoAdvocate Oswald Peterson discusses his experience receiving a PD-1 checkpoint inhibitor for stage 4 non-small cell…
-
Dr. Kunle Odunsi Answers Questions About Ovarian Cancer and Immunotherapy From the 2020 CRI Virtual Immunotherapy Patient Summit
Dr. Kunle Odunsi of Roswell Park Comprehensive Cancer Center answers questions about ovarian cancer and immunotherapy from…
-
Dr. Ezra Cohen Answers Questions About Immunotherapy Clinical Trials from the 2020 CRI Virtual Immunotherapy Patient Summit
Dr. Ezra Cohen, of UC San Diego Moores Cancer Center, answers questions about immunotherapy clinical trials from…
-
Ovarian Cancer and Immunotherapy Breakout Session at the 2020 CRI Virtual Immunotherapy Patient Summit
Dr. Kunle Odunsi discusses genomic testing, new treatments, and promising clinical trials in immunotherapy for ovarian cancer.
-
Dr. Sumit Subudhi Answers Questions on Prostate Cancer and Immunotherapy from the CRI Virtual Immunotherapy Patient Summit
Sumit K. Subudhi, MD, PhD, answers questions on immunotherapy for prostate cancer from the 2020 CRI Virtual Immunotherapy…
-
Immunotherapy Clinical Trials with Dr. Ezra Cohen at the 2020 CRI Virtual Immunotherapy Patient Summit
Dr. Ezra Cohen addresses myths, questions, and other concerns about cancer immunotherapy clinical trials at the 2020…
-
Dr. Leena Gandhi Answers Questions About Immunotherapy for Lung Cancer from the 2020 CRI Virtual Immunotherapy Patient Summit
Dr. Leena Gandhi, of Dana-Farber Cancer Institute, answers questions about immunotherapy for lung cancer from the 2020…